D de Mouy
Overview
Explore the profile of D de Mouy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin D, Fougnot S, Grobost F, Thibaut-Jovelin S, Ballereau F, Gueudet T, et al.
J Infect
. 2015 Dec;
72(2):201-6.
PMID: 26702736
Objectives: We sought to assess the importance of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae in urinary tract infections in outpatients in France. Methods: Retrospective laboratory based survey analysing susceptibility patterns of...
2.
Augereau C, Couaillac J, de Mouy D, Dezier J, Fonfrede M, Lepargneur J, et al.
Ann Biol Clin (Paris)
. 2010 Feb;
68(1):113-9.
PMID: 20146982
We critically appraised the methodological quality of the clinical practice guideline (CPG) published by the Haute autorité de santé (HAS) about screening and diagnosis of gestational diabetes, and we compared...
3.
Augereau C, Couaillac J, de Mouy D, Dezier J, Fonfrede M, Lepargneur J, et al.
Ann Biol Clin (Paris)
. 2009 Aug;
67(4):477-83.
PMID: 19654090
A growing number of clinical practice guidelines (CPG) is published. This is understandable because CPG are the corner stone in the evaluation of professional practices (EPP). One cannot deny that...
4.
de Mouy D, Fabre R, Cavallo J, Arzouni J, Baynat M, Bicart-See A, et al.
Med Mal Infect
. 2007 Jan;
37(9):594-8.
PMID: 17258415
Objectives: A multicenter study was implemented in order to determine the distribution and antibiotic susceptibility patterns of strains isolated from 15 to 65 year old female patients with community-acquired urinary...
5.
Ficca G, Chauvel M, de Mouy D
Med Mal Infect
. 2006 Apr;
36(4):207-12.
PMID: 16600552
Objective: The authors had for aim to assess the prevalence of community-acquired methicillin-resistant Staphylococcus aureus in France. Method: Two hundred fifty-four strains identified in 1,079 nasal samples from voluntary individuals...
6.
Arzouni J, Bouilloux J, de Mouy D, Bicart-See A, Charbit C, Doeschler T, et al.
Med Mal Infect
. 2004 Dec;
34(2):92-6.
PMID: 15620021
One thousand eight hundred and thirty-six clinical and biological cervico-vaginal flora samples from genital infections in women observed in community practice in 1987 were compared to 368 samples collected in...
7.
de Mouy D, Cavallo J, Leclercq R, Fabre R
Antimicrob Agents Chemother
. 2001 Jul;
45(8):2400-2.
PMID: 11451709
Among 126 Streptococcus agalactiae isolates collected in 10 French laboratories in 1999, 27 (21.4%) had macrolide resistance related to the presence of erm(B) (11 strains), erm(A) subclass erm(TR) (10 strains),...
8.
de Mouy D, Cavallo J, Armengaud M, Arzouni J, Berges J, Bouilloux J, et al.
Presse Med
. 1999 Nov;
28(30):1624-8.
PMID: 10544691
Objective: The aim of this study was to explore the relationship between etiological factors, bacterial isolates and Escherichia coli susceptibility to antibiotics in ambulatory patients with urinary tract infection. Patients...
9.
Bousquet B, Charret J, Dreux C, Gruson A, Marcelli A, de Mouy D, et al.
Ann Biol Clin (Paris)
. 1998 Dec;
56(4):504-7.
PMID: 9841576
No abstract available.
10.
de Mouy D
Int J Antimicrob Agents
. 1992 Dec;
2(1):15-7.
PMID: 18611514
The Lomefloxacin International Surveillance Trial (LIST) is an in vitro testing program specifically designed to assess the antimicrobial activity of lomefloxacin against a wide range of clinical isolates from hospitals,...